• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用终末期肝病模型(MELD)评分系统预测慢性乙型肝炎急性发作患者的预后

Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system.

作者信息

Yu Jian-Wu, Wang Gui-Qiang, Li Shu-Chen

机构信息

Department of Infectious Diseases, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.

出版信息

J Gastroenterol Hepatol. 2006 Oct;21(10):1519-24. doi: 10.1111/j.1440-1746.2006.04510.x.

DOI:10.1111/j.1440-1746.2006.04510.x
PMID:16928211
Abstract

AIM

To predict prognosis in patients with acute-on-chronic hepatitis (AOCH) using the model for end-stage liver disease (MELD) scoring system and to study the effects of age, sex, etiology, low serum sodium, and persistent ascites on MELD.

METHODS

The MELD scores of 300 patients with AOCH were calculated according to the original formula. The 3-month mortality in patients was measured, and the validity of the models was determined by means of the concordance (c) statistic. The influential factors on MELD were also assessed.

RESULTS

The 3-month mortality of AOCH patients with a MELD score of 20-29 was 56.0%, with a score of 30-39 it was 76.5%, and with a score over 40 it was 98.2%. The concordance (c) statistic of 3-month mortality was 0.782. Univariate analysis showed that mortality was significantly related to age (P=0.047), etiology (P=0.039), serum sodium (P=0.029) and ascites (P=0.031) for patients with MELD scores 20-29. In multivariate analysis, in patients with MELD scores 20-29, age (P=0.012), etiology (P=0.024), serum sodium (P=0.005) and ascites (P=0.017) were independent predictors of mortality; for MELD scores above 30, only MELD score (P=0.015) was independently predictive.

CONCLUSIONS

The MELD scoring system is a reliable method for predicting mortality in patients with AOCH. In the group with MELD score 20-29, factors including age, etiology, presence of low serum sodium and persistent ascites may influence the MELD scoring system. The MELD score is the decisive predictor of the prognosis of patients with AOCH when the MELD score is over 30.

摘要

目的

使用终末期肝病模型(MELD)评分系统预测慢加急性肝炎(AOCH)患者的预后,并研究年龄、性别、病因、低血钠及持续性腹水对MELD的影响。

方法

根据原始公式计算300例AOCH患者的MELD评分。测定患者的3个月死亡率,并通过一致性(c)统计量确定模型的有效性。还评估了对MELD有影响的因素。

结果

MELD评分为20 - 29分的AOCH患者3个月死亡率为56.0%,评分为30 - 39分者为76.5%,评分超过40分者为98.2%。3个月死亡率的一致性(c)统计量为0.782。单因素分析显示,MELD评分为20 - 29分的患者,死亡率与年龄(P = 0.047)、病因(P = 0.039)、血钠(P = 0.029)及腹水(P = 0.031)显著相关。多因素分析显示,MELD评分为20 - 29分的患者,年龄(P = 0.012)、病因(P = 0.024)、血钠(P = 0.005)及腹水(P = 0.017)是死亡率的独立预测因素;MELD评分高于30分者,只有MELD评分(P = 0.015)具有独立预测性。

结论

MELD评分系统是预测AOCH患者死亡率的可靠方法。在MELD评分为20 - 29分的组中,年龄、病因、低血钠及持续性腹水等因素可能影响MELD评分系统。当MELD评分超过30分时,MELD评分是AOCH患者预后的决定性预测因素。

相似文献

1
Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system.使用终末期肝病模型(MELD)评分系统预测慢性乙型肝炎急性发作患者的预后
J Gastroenterol Hepatol. 2006 Oct;21(10):1519-24. doi: 10.1111/j.1440-1746.2006.04510.x.
2
Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.使用终末期肝病评分系统模型和新型逻辑回归模型预测慢性乙型肝炎急性肝衰竭患者的预后
J Viral Hepat. 2009 Jul;16(7):464-70. doi: 10.1111/j.1365-2893.2008.01046.x. Epub 2009 Apr 29.
3
Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.终末期肝病评分系统模型对慢性乙型肝炎急性肝衰竭患者血浆置换联合拉米夫定治疗后预后的预测价值。
J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1242-9. doi: 10.1111/j.1440-1746.2008.05484.x. Epub 2008 Jul 10.
4
[MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].[终末期肝病模型(MELD)评分对经颈静脉肝内门体分流术(TIPS)治疗的顽固性腹水患者早期死亡率的预测作用]
Vnitr Lek. 2006 Sep;52(9):771-6.
5
Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.终末期肝病-钠模型可预测慢性重型乙型肝炎患者的预后。
Chin Med J (Engl). 2008 Oct 20;121(20):2065-9.
6
The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment.用于预测血浆置换治疗后重症肝炎患者预后的终末期肝病模型(MELD)评分系统。
Hepatobiliary Pancreat Dis Int. 2007 Oct;6(5):492-6.
7
Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.终末期肝病评分与血清钠比值指数模型作为肝硬化患者预后预测指标的验证
J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.
8
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.持续性腹水和低血钠可识别出肝硬化且终末期肝病模型(MELD)评分低但早期死亡风险高的患者。
Hepatology. 2004 Oct;40(4):802-10. doi: 10.1002/hep.20405.
9
Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.慢性乙型肝炎急性肝衰竭患者原位肝移植中移植前终末期肝病模型(MELD)评分对移植后结局的影响
Transplant Proc. 2007 Jun;39(5):1501-4. doi: 10.1016/j.transproceed.2007.02.070.
10
Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.终末期肝病模型对失代偿期慢性乙型肝炎患者死亡率的预测评估
Am J Gastroenterol. 2006 Jul;101(7):1516-23. doi: 10.1111/j.1572-0241.2006.00659.x.

引用本文的文献

1
Challenges and Solutions for Monitoring Alcohol Use in Patients With Alcohol-Related Liver Disease: Pilot Study of a Wearable Alcohol Biosensor.监测酒精相关性肝病患者饮酒情况的挑战和解决方案:可穿戴酒精生物传感器的初步研究。
Psychosom Med. 2023 Sep 1;85(7):596-604. doi: 10.1097/PSY.0000000000001203. Epub 2023 Apr 17.
2
Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.肝脏再生对乙型肝炎相关性慢加急性肝衰竭患者短期预后预测的价值。
Biomed Res Int. 2020 Aug 6;2020:5062873. doi: 10.1155/2020/5062873. eCollection 2020.
3
How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure?
如何在小儿慢加急性肝衰竭中识别肝移植的需求?
Hepatol Int. 2018 Nov;12(6):552-559. doi: 10.1007/s12072-018-9901-y. Epub 2018 Oct 19.
4
Bacterial Infection and Predictors of Mortality in Patients with Autoimmune Liver Disease-Associated Acute-On-Chronic Liver Failure.自身免疫性肝病相关慢加急性肝衰竭患者的细菌感染与死亡预测因素。
Can J Gastroenterol Hepatol. 2018 Jan 28;2018:5108781. doi: 10.1155/2018/5108781. eCollection 2018.
5
Acute on Chronic Liver Failure-What is in a 'Definition'?慢性肝病急性肝衰竭——“定义”里包含了什么?
J Clin Exp Hepatol. 2016 Sep;6(3):233-240. doi: 10.1016/j.jceh.2016.08.011. Epub 2016 Sep 1.
6
Model for End-Stage Liver Disease and liver cirrhosis-related complications.终末期肝病模型及肝硬化相关并发症
Hepatol Int. 2013 Jun;7(2):347-55. doi: 10.1007/s12072-012-9403-2. Epub 2012 Oct 10.
7
Clinical profile, natural history, and predictors of mortality in patients with acute-on-chronic liver failure (ACLF).慢加急性肝衰竭(ACLF)患者的临床特征、自然病史及死亡预测因素
Wien Klin Wochenschr. 2015 Apr;127(7-8):283-9. doi: 10.1007/s00508-015-0707-9. Epub 2015 Mar 28.
8
Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure.将血清胱抑素C与总胆红素相结合可改善乙肝相关慢加急性肝衰竭患者短期死亡率的预测。
PLoS One. 2015 Jan 28;10(1):e0116968. doi: 10.1371/journal.pone.0116968. eCollection 2015.
9
A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients.一个用于中国慢加急性肝衰竭前期(pre-ACLF)和慢加急性肝衰竭(ACLF)患者的改良 MELD 模型,该模型显示在 pre-ACLF 患者中预后不良。
PLoS One. 2013 Jun 5;8(6):e64379. doi: 10.1371/journal.pone.0064379. Print 2013.
10
Predictors of outcome in acute-on-chronic liver failure in children.儿童慢加急性肝衰竭预后的预测因素。
Hepatol Int. 2011 Jun;5(2):693-7. doi: 10.1007/s12072-010-9217-z. Epub 2010 Dec 28.